Clinical Twin™ DNA is IntuScribe's personalisation technology for medical documentation. It is designed to help IntuScribe produce AI medical note drafts that better match the clinician who will review them: their preferred structure, wording, clinical tone, shorthand, level of detail, and output format.

Most AI scribe tools can generate a generic consultation note. The harder problem is what happens after the first draft. Clinicians often spend time changing headings, reordering sections, replacing vocabulary, shortening paragraphs, or converting a generic note into the format their practice actually uses. IntuScribe's Clinical Twin™ DNA is built to reduce that repetitive editing burden.

The purpose is practical, not magical: IntuScribe uses Clinical Twin™ DNA to shape the presentation of a draft so it is closer to the clinician's preferred documentation style. It does not turn IntuScribe into the clinician, and it does not make a note correct by default. Facts, reasoning, diagnoses, management decisions, billing decisions, and final sign-off remain with the responsible clinician.

How does Clinical Twin™ DNA personalise AI medical notes

Clinical Twin™ DNA is an IntuScribe technology layer for personalised AI medical notes.
It focuses on recurring documentation preferences: note structure, clinical tone, shorthand, vocabulary, headings, templates, and output style.
IntuScribe uses personalisation to reduce repetitive editing after the first AI scribe draft.
Personalisation should improve workflow fit; it should not invent clinical reasoning or override clinician review.
A familiar-sounding note still needs careful checking for omissions, wrong negations, medication errors, dates, and inappropriate certainty.
Privacy, consent, access control, retention, reset, and opt-out settings should be understood before using any personalised documentation workflow.

What is IntuScribe Clinical Twin™ DNA?

IntuScribe Clinical Twin™ DNA is a personalisation layer within the IntuScribe clinical documentation workflow. It is designed to help the platform understand how an individual clinician prefers notes to be structured and phrased, then apply those preferences when preparing future drafts.

For example, one GP may prefer a compact problem-oriented note with short bullet points. Another clinician may prefer SOAP headings with a fuller assessment and plan. A psychologist may need a more narrative style, while a physiotherapist or occupational therapist may want structured objective findings, functional observations, goals, and actions. IntuScribe's Clinical Twin™ DNA exists because these preferences matter in real clinical work.

A useful boundary is:

Style: “Use a concise Assessment and Plan with bullet points.”
Terminology: “Use Australian spelling and familiar clinical shorthand where safe.”
Structure: “Place medications, assessment, and follow-up in this sequence.”
Output purpose: “Create a progress note, patient summary, referral letter, or handover in the appropriate format.”
Clinical judgement: “This patient has condition X and should receive treatment Y.”

The first four are appropriate targets for IntuScribe personalisation. The last is a clinical decision. IntuScribe can help organise the note around the consultation and the clinician's verified reasoning, but the decision must be grounded in the patient encounter, available record, and clinician review.

Why IntuScribe built Clinical Twin™ DNA

Clinicians do not simply need more transcription. They need documentation that fits how they practise.

A generic AI medical scribe may produce an accurate-enough first draft but still create friction because it uses the wrong headings, the wrong level of detail, the wrong tone, or a structure that does not match the clinician's template. Across a full clinic, small edits become a significant administrative load.

IntuScribe built Clinical Twin™ DNA to address this gap between generic AI scribing and clinician-ready documentation. Instead of treating every clinician as if they write the same way, IntuScribe aims to make the draft feel closer to the clinician's normal workflow before the review step begins.

Clinical Twin™ DNA can support IntuScribe workflows such as:

GP notes: concise history, examination, assessment, plan, safety-netting, referrals, and follow-up.
Allied health notes: therapy goals, functional observations, participant-centred language, progress, and actions.
Psychology notes: session themes, mental state observations where appropriate, risk language requiring clinician review, and treatment planning.
Specialist notes: clinical context, correspondence-ready summaries, and structured plans.
Referral letters and patient summaries: different outputs from the same consultation context, written for different audiences.

What can Clinical Twin™ DNA personalise?

IntuScribe Clinical Twin™ DNA is most useful when it learns patterns that are genuinely about documentation style and workflow. These may include:

Area	How IntuScribe Clinical Twin™ DNA can help	What still needs clinician review
Note structure	Preferred headings, ordering, SOAP or problem-oriented format	Whether the structure accurately reflects the consultation
Clinical tone	Objective, concise, patient-centred, or correspondence-ready wording	Whether the tone is appropriate for the recipient and clinical context
Shorthand	Familiar abbreviations where clear and accepted	Whether an abbreviation could be misunderstood
Level of detail	Short progress note versus fuller letter or handover	Whether important information has been omitted
Templates	Practice or specialty-specific formatting	Whether the template suits the actual encounter
Multi-document outputs	Different wording for notes, referral letters, summaries, and tasks	Whether each document is accurate and suitable before use

This is why Clinical Twin™ DNA is different from a simple prompt. A prompt can ask for a style once. IntuScribe's personalisation layer is intended to reduce the need to repeat the same instruction every time a clinician generates a note.

For shorthand-specific context, see how AI scribes learn clinical abbreviations. For practice-wide consistency, read medical note templates and practice standards.

How IntuScribe personalisation should work safely

The safest model separates a draft, an approved note, and a preference signal. IntuScribe's Clinical Twin™ DNA should be understood through that lens: it may help the draft fit the clinician better, but the clinician remains responsible for verifying the record.

Stage	Example in IntuScribe	Safety principle
1. Consultation	The clinician uses IntuScribe with appropriate consent and workflow controls	Capture the relevant encounter; do not assume silence means a negative finding
2. First AI scribe draft	IntuScribe generates a structured draft note	Keep it as a draft until reviewed
3. Clinician edit	The clinician changes a heading, removes an unsupported statement, or corrects medication details	Distinguish style preferences from clinical corrections
4. Preference signal	Repeated formatting choices may indicate a documentation preference	Do not convert safety corrections into learned clinical assumptions
5. Finalisation	The clinician verifies facts, reasoning, and plan	Only the reviewed version should become the clinical record
6. Ongoing control	Preferences are reviewed, adjusted, paused, reset, or removed as needed	Keep the clinician and practice in control

For example, if a clinician repeatedly changes “History of Presenting Complaint” into dated bullet points, that may be a useful Clinical Twin™ DNA preference. If the clinician removes “no chest pain” because chest pain was never discussed, that is not a style preference; it is a correction to the clinical content. IntuScribe personalisation should not teach the system to repeat unsupported clinical statements.

Clinical Twin™ DNA is not clinical reasoning

A note that sounds like you can still be wrong. This is one of the most important safety points for any personalised AI scribe.

IntuScribe Clinical Twin™ DNA may make a draft easier to read because it matches the clinician's usual format. That familiarity is useful, but it can also make errors less obvious if the clinician reviews too quickly. Before signing or transferring any AI-generated note into the clinical record, check:

patient identity and encounter date;
symptoms and negatives actually established;
examination findings performed, not assumed;
medicines, doses, allergies, and changes;
investigations, dates, units, and results;
assessment certainty and differential diagnoses;
referrals, follow-up, safety-netting, and responsibilities; and
whether the note is suitable for its intended recipient.

IntuScribe should support the clinician's documentation process, not replace clinical judgement. Clinical Twin™ DNA is therefore best understood as a workflow-fit technology: it can help the draft feel more like the clinician's preferred note, but the clinician must still decide whether the content is correct.

Privacy and trust boundaries for IntuScribe Clinical Twin™ DNA

Personalised documentation technology needs clear privacy boundaries because clinical notes can contain sensitive health information. A preference such as “use bullet points” is very different from a patient's medication history, diagnosis, or psychosocial details. The boundary between style preference and patient content should be explicit.

When using IntuScribe Clinical Twin™ DNA, practices should understand:

what information is used to shape personalisation;
whether style preferences are separated from patient-linked content;
who can access drafts, transcripts, final notes, and preference history;
where information is stored and processed;
how long audio, transcripts, drafts, notes, and preference signals are retained;
whether personalisation can be paused, reset, corrected, or deleted; and
how account settings align with the practice's consent, privacy, and retention policies.

The published starting points are the IntuScribe Trust Center and IntuScribe privacy policy. For a deeper healthcare-specific discussion, see digital health data retention and deletion questions and the OAIC guidance on health information.

Opt-out, reset, and control questions

Before relying heavily on any personalised AI medical scribe workflow, confirm the controls available for the IntuScribe account and practice configuration:

Pause or opt-out: Can personalisation be paused while the clinician continues to use AI scribing?
Scope: Does pausing apply to future learning only, or also to existing preferences?
Reset: Can Clinical Twin™ DNA preferences be reset without deleting clinical records?
Correction: Can a clinician remove a learned preference that is wrong or no longer suitable?
Deletion: Can preference data, drafts, transcripts, audio, and patient-linked outputs be managed separately where required?
Auditability: Is there visibility over when a preference was applied or changed?
Migration: Can the practice export relevant records before closure or migration?
Governance: Who in the practice can configure templates, personalisation settings, and access controls?

These questions do not make the product weaker. They make the implementation safer. IntuScribe's value is strongest when Clinical Twin™ DNA is used with clear clinician control, practice governance, and documented review responsibilities.

How to implement Clinical Twin™ DNA in a clinic

A measured rollout works better than switching every note type at once.

Start with a small group of clinicians and one or two common note types. Define the expected template, acceptable shorthand, prohibited inferences, review steps, and escalation route for errors. Compare IntuScribe drafts with signed notes, paying attention to time saved, edits still required, and any safety concerns.

Then refine the workflow:

decide which preferences belong to an individual clinician and which belong to the practice;
keep shared templates consistent for medico-legal and continuity purposes;
train clinicians to distinguish style edits from clinical corrections;
review personalisation after role, specialty, or practice changes; and
keep a fallback template for encounters where personalisation is not appropriate.

This approach lets IntuScribe's Clinical Twin™ DNA improve documentation fit without allowing convenience to outrun clinical safety.

Frequently asked questions

Is Clinical Twin™ DNA an IntuScribe technology?

Yes. Clinical Twin™ DNA is IntuScribe's personalisation technology for medical notes. It is designed to help IntuScribe draft documentation in a way that better matches the clinician's preferred structure, tone, shorthand, and template style.

Does IntuScribe Clinical Twin™ DNA replace clinician review?

No. IntuScribe Clinical Twin™ DNA can personalise the presentation of a draft, but the responsible clinician must verify the clinical facts, interpretation, plan, and suitability of the final record.

Is a personalised IntuScribe note automatically more accurate?

No. Personalisation may reduce repetitive editing, but it does not prove the content is complete or correct. A familiar format can still contain omissions, wrong dates, incorrect negations, medication errors, or unsupported certainty.

Can Clinical Twin™ DNA learn my clinical judgement?

It should not be treated as learning independent clinical judgement. IntuScribe personalisation can support recurring documentation preferences, while clinical decisions must come from the current patient encounter, record, and responsible clinician.

Can IntuScribe use my preferred abbreviations?

IntuScribe Clinical Twin™ DNA may support preferred shorthand where it is clear and appropriate, but abbreviations should not be used where they could confuse a patient, colleague, specialist, insurer, or other reader.

Can I reset or change what Clinical Twin™ DNA has learned?

Confirm the available controls for your IntuScribe configuration. In general, practices should understand how personalisation can be paused, corrected, reset, or deleted separately from clinical records where applicable.

Interested in reducing repetitive note editing with IntuScribe Clinical Twin™ DNA? Explore IntuScribe, then review the Trust Center and privacy policy for IntuScribe's published privacy and security approach.

Clinical Twin™ DNA: Personalising Your Medical Notes